Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases-Reference-Cited by-同舟云学术

Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases

Published:2014-04 Issue:1-2 Volume:465 Page:317-324
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

ter Heine Rob,Lange Rogier,Breukels Oscar,Bloemendal Haiko J.,Rummenie Rob G.,Wakker Antoinette M.,de Graaf Hilly,Beekman Freek J.,van der Westerlaken Monique M.L.,Malingré Mirte M.,Wielders Jos P.M.,van den Berg Leo,Hendrikse N. Harry,de Klerk John M.H.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference28 articles.

1. Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP;Bergqvist;Acta Radiol. Diagn. (Stockh.),1984

2. Pixel-based subsets for rapid multi-pinhole SPECT reconstruction;Branderhorst;Phys. Med. Biol.,2010

3. The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine;Deutsch;Int. J. Radiat. Appl. Instrum. B,1986

4. Studies of the structure and composition of Rhenium-1,1-hydroxyethylidenediphosphonate (HEDP) analogues of the radiotherapeutic agent (186)ReHEDP;Elder;Inorg. Chem.,1997

5. European Pharmacopoeia edition 7.8;European Pharmacopoeia Commission,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis;Annals of Nuclear Medicine;2023-12-25

2. Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry;Molecules;2023-02-03

3. Radiopharmaceuticals;Practical Pharmaceutics;2023

4. Radiometal-theranostics: the first 20 years*;Journal of Radioanalytical and Nuclear Chemistry;2022-11-24

5. Targeted Radionuclide Therapy for Bone Metastasis;Nuclear Oncology;2022